Open AccessSRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors
Author(s) -
Hiroki Sato,
Daisuke Kubota,
Huan Qiao,
Achim A. Jungbluth,
Natasha Rekhtman,
Adam J. Schoenfeld,
Helena A. Yu,
Gregory J. Riely,
Shinichi Toyooka,
Christine M. Lovly,
Paul K. Paik,
Marc Ladanyi,
PangDian Fan
Publication year - 2022
Publication title -
jco precision oncology
Language(s) - English
Resource type - Journals
ISSN - 2473-4284
DOI - 10.1200/po.22.00088
Subject(s) - cancer research , epidermal growth factor receptor , carcinogenesis , yap1 , lung cancer , cancer , tyrosine kinase , adenocarcinoma , biology , medicine , pathology , signal transduction , microbiology and biotechnology , transcription factor , genetics , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom